ARC Fertility

11/12/2025

New research in The Lancet Obstetrics, Gynaecology, & Women’s Health calls for national action on endometriosis, and ARC Fertility is proud to spotlight this landmark work.

Led by global experts and supported by International Federation of Fertility Societies (IFFS) and the International Committee for Monitoring Assisted Reproductive Technologies (ICMART), the studies reveal major policy gaps and urge coordinated responses to improve diagnosis and care. As Dr. David Adamson notes, “Endometriosis must be recognized as a chronic condition requiring coordinated national responses.” Learn more: https://www.globenewswire.com/news-release/2025/11/12/3186454/0/en/ARC-Fertility-Highlights-Landmark-Global-Studies-Published-in-The-Lancet-Calling-for-National-Action-on-Endometriosis.html

ARC Fertility Highlights Landmark Global Studies Published in The Lancet Calling for National Action on Endometriosis...

11/11/2025

The FDA’s decision to remove black box warnings from hormone therapy reflects a long-awaited shift toward evidence-based, individualized care for women in menopause. This update acknowledges the real benefits these therapies can provide for heart, brain, bone health and quality of life.

At ARC Fertility, we support informed choices and access to care across every stage of reproductive health. Learn more: https://www.statnews.com/2025/11/10/fda-reverses-hormone-warning-menopause-health/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz-_Afe3eJ2CecJv-JIzafLaGCvipAXpvBcCayhKCdCjtC334PlkDvnUOQFY2baKvAa8xQrItgDUxHthfBoEjNMfupKsrTA&_hsmi=389313604&utm_content=389313604&utm_source=hs_email

The FDA is reversing a 2003 decision that put a stringent warning on hormone therapy products for menopausal women, saying that the treatments offer heart, brain, and bone health benefits.

11/10/2025

Menopause affects nearly half of women in the workforce, yet many benefit programs still don’t address it. Modern hormone therapy can safely reduce symptoms and help employees stay productive and engaged.

Our latest blog explains why menopause support is becoming a workplace priority and how employers can take meaningful action. At ARC Fertility we offer evidence-based, inclusive hormonal health support across all life stages. Read more: https://www.arcfertility.com/menopause-and-hormone-therapy-what-employers-need-to-know-to-support-a-changing-workforce/

Menopause and hormone therapy are key issues affecting workforce health and productivity. Learn why employers should include menopause support in benefits plans.

11/05/2025

David Adamson, CEO and April Lee, COO, ARC Fertility, recently participated in the American Society for Reproductive Medicine - (ASRM) 2025 Scientific Congress & Expo, a gathering that brings together leaders advancing reproductive medicine and improving access to care worldwide.

Spotlighted was the David and Rosemary Adamson Lecture on Excellence in Reproductive Medicine, introduced by Dr. Michael Thomas, featuring Dr. Natalia Kanem on the global future of reproductive health. Grateful to connect with colleagues in ATCSIG and past ASRM presidents continuing to drive progress.

11/03/2025

A new article in The Lancet Obstetrics, Gynaecology, & Women’s Health co-authored by ARC Fertility Founder & CEO Dr. David Adamson calls for fertility awareness and reproductive choice to become global public health priorities.

The message is clear: equitable access to fertility care is essential. Employers have the power to lead by offering inclusive, evidence-based fertility benefits that reflect modern families and workforce needs. Read more: https://www.arcfertility.com/fertility-awareness-and-reproductive-choice-a-public-health-priority-employers-cant-ignore/

Global fertility rates are declining. ARC Fertility’s Dr. David Adamson calls for urgent action on fertility awareness and reproductive choice worldwide.

10/31/2025

A new analysis shows that maternal mortality rates in some U.S. states mirror those of developing nations, highlighting how deeply uneven access to care remains across the country.

As Mississippi’s infant mortality crisis demonstrates, gaps in prenatal support and family benefits can have devastating consequences. Employers have an opportunity to help close these gaps by offering equitable, inclusive and accessible benefits that support families before, during and after pregnancy, creating healthier outcomes and stronger, more resilient workplaces: https://www.axios.com/2025/10/20/maternal-mortality-states-countries

And read more in our recent blog on Mississippi’s infant mortality crisis here: https://www.arcfertility.com/mississippis-infant-mortality-crisis-how-employers-can-help-protect-families-with-better-benefits/

Some states have rates comparable to El Salvador, Belize and Azerbaijan.

10/29/2025

Fertility benefits are now an expectation, yet emerging embryo personhood laws could put IVF and other reproductive care at risk. Leading research shows that defining embryos as legal persons could limit access to safe, effective fertility treatments.

ARC Fertility helps employers navigate these legal and clinical shifts to protect their benefits programs and support workforce well-being. Learn more: https://www.arcfertility.com/fertility-care-at-risk-what-employers-need-to-know-about-embryo-personhood-laws/

Embryo personhood laws threaten fertility care access. Learn how employers can protect benefits and support employees with science-based reproductive policies.

10/22/2025

A new UCLA study shows that while egg freezing is becoming more common, only about 6% of women have returned to use their eggs within seven years.

The findings underscore the importance of informed consent, realistic expectations and medical guidance. At ARC Fertility, we help patients make confident, well-informed choices about egg freezing as part of their family-building journey. Learn more: https://rewirenewsgroup.com/2025/10/17/new-study-ivf-egg-freezing-ucla/

A new UCLA study found that only about 6 percent of people who froze their eggs between 2014 and 2021 ultimately came back for in vitro fertilization.

10/20/2025

Expanding access to in vitro fertilization (IVF) is critical for the 1 in 6 people worldwide who face infertility. Recent guidance supporting broader IVF coverage highlights how essential fertility benefits are for families and employers.

At ARC Fertility, we’ve spent over two decades making fertility care more affordable, accessible and supported for employers and families alike. We applaud any initiative that improves access to quality IVF treatment so more families can achieve their dream of parenthood. Learn more: https://www.fiercehealthcare.com/regulatory/trump-admin-takes-aim-cost-ivf-new-coverage-guidance

The Trump administration is making a new push to expand access to fertility benefits, aligning with a key promise made on the campaign trail. | The Trump administration is making a new push to expand access to fertility benefits, aligning with a key promise made on the campaign trail.

10/15/2025

Menopause impacts millions of female employees during their careers, yet it often goes unsupported in the workplace. ARC Fertility’s Inclusive Menopause Benefit Offering provides compassionate, evidence-based care that helps employees manage symptoms, stay engaged and feel supported.

With access to specialists, mental health resources, flexible care options and pharmacy benefits, employers can foster a healthier, more inclusive culture while improving retention and productivity. Learn more about ARC’s comprehensive support solutions and contact us today to schedule a demo: https://www.arcfertility.com/menopause/

ARC’s Inclusive Menopause Benefit Offering  A key component of ARC Fertility’s commitment to providing comprehensive family-forming and reproductive

10/13/2025

Mississippi faces the highest infant mortality rate in the U.S., a public health emergency that demands action. Limited access to maternity care and prenatal support puts families and employers at risk.

ARC Fertility partners with organizations nationwide to improve access to quality reproductive care, education and early intervention that support healthier pregnancies and stronger workplaces. Read our latest blog to learn how employers can make a meaningful impact in Mississippi and beyond: https://www.arcfertility.com/mississippis-infant-mortality-crisis-how-employers-can-help-protect-families-with-better-benefits/

Mississippi’s infant mortality rate is the highest in the country. Learn how ARC Fertility helps employers protect employee health and improve pregnancy outcomes through better benefits and care access.